Research and Evidence
The research studying the effects of the Enara program and methods have shown significant evidence in the improvement of health outcomes related to obesity and type 2 diabetes.
Data for 233 patients enrolled in this precision medicine weight loss program were analyzed. Patients at 3, 6, and 12 months lost on average 11.99% , 13.87%, and 11.16% of baseline weight, respectively.
At week 72, AOM users (N = 71) achieved significantly greater mean percentage reduction in baseline weight than non‐users (N = 58). On average, baseline weight decreased by 14.04 ± 6.2% in users versus 10.9 ± 6.8% in non‐users (P = 0.008); 84% and 94% of non‐user and AOM users lost >5% weight loss (P = 0.006).
"Recent guidelines generally recommend anti‐obesity medications (AOMs) only for patients who have failed to achieve 5% weight loss through dietary, exercise and/or lifestyle modification interventions alone 1-5. However, the optimal time to introduce an AOM in the setting of a comprehensive weight loss programme has not been well studied..."
"Our study demonstrated that all patients who participated in this hybrid digital and in-person weight loss program lost >11% of their baseline weight across multiple time points. Leveraging the real-time connectivity, tailored elements, and engagement of a mobile app may benefit weight loss programs."
"Participants in the Enara Health precision weight loss program lost an average of -13.99% at 18 months. Self tracking and increased provider-patient touch points characterized high achievers at 18 months. Mobile health applications may be better suited to achieve sustained weight loss by designing features that facilitate provider-patient interactions on top of self tracking technology."
"This retrospective study aimed to evaluate the impact of Anti‐Obesity Medication (AOM) initiation, usage and duration on weight loss in a 72‐week precision obesity program. The type of AOM, diet and exercise plan was chosen based upon an individual's biological and psychosocial needs. The 72‐week study duration allowed for a fair investigation of the downstream impact of delayed vs early AOM initiation "
Partner with us
California | 1650 South Amphlett Blvd, Ste 115
San Mateo, CA 94402
Texas | 6155 Sports Village Rd Suite 200, Frisco, TX 75033
Illinois | 16501 106th Court
Orland Park, Illinois 60467